181 related articles for article (PubMed ID: 34543755)
1. Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity.
Zhao Y; Chen X; He C; Gao G; Chen Z; Du J
Bioorg Med Chem Lett; 2021 Nov; 51():128361. PubMed ID: 34543755
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
[TBL] [Abstract][Full Text] [Related]
3. Synthetic 1,4-Naphthoquinones inhibit P2X7 receptors in murine neuroblastoma cells.
Pislyagin E; Kozlovskiy S; Menchinskaya E; Chingizova E; Likhatskaya G; Gorpenchenko T; Sabutski Y; Polonik S; Aminin D
Bioorg Med Chem; 2021 Feb; 31():115975. PubMed ID: 33401207
[TBL] [Abstract][Full Text] [Related]
4. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
[TBL] [Abstract][Full Text] [Related]
5. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
Zhang WJ; Hu CG; Zhu ZM; Luo HL
Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
[TBL] [Abstract][Full Text] [Related]
6. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
[TBL] [Abstract][Full Text] [Related]
7. Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists.
Caseley EA; Muench SP; Fishwick CW; Jiang LH
Biochem Pharmacol; 2016 Sep; 116():130-9. PubMed ID: 27481062
[TBL] [Abstract][Full Text] [Related]
8. Arylboronic acids inhibit P2X7 receptor function and the acute inflammatory response.
Faria RX; de Jesus Hiller N; Salles JP; Resende JALC; Diogo RT; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; de Luna Martins D
J Bioenerg Biomembr; 2019 Aug; 51(4):277-290. PubMed ID: 31256283
[TBL] [Abstract][Full Text] [Related]
9. Roles of purinergic P2X
McLarnon JG
Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
[TBL] [Abstract][Full Text] [Related]
10. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
Li Q; Zhu X; Song W; Peng X; Zhao R
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
[TBL] [Abstract][Full Text] [Related]
11. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor.
Fresta CG; Caruso G; Fidilio A; Platania CBM; Musso N; Caraci F; Drago F; Bucolo C
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291318
[TBL] [Abstract][Full Text] [Related]
12. Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
Allsopp RC; Dayl S; Schmid R; Evans RJ
Sci Rep; 2017 Apr; 7(1):725. PubMed ID: 28389651
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of purinergic P2X receptor 7 (P2X7R) decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) expression in U251 glioblastoma cells.
Drill M; Powell KL; Kan LK; Jones NC; O'Brien TJ; Hamilton JA; Monif M
Sci Rep; 2020 Sep; 10(1):14844. PubMed ID: 32908225
[TBL] [Abstract][Full Text] [Related]
14. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.
Kwak SH; Shin S; Lee JH; Shim JK; Kim M; Lee SD; Lee A; Bae J; Park JH; Abdelrahman A; Müller CE; Cho SK; Kang SG; Bae MA; Yang JY; Ko H; Goddard WA; Kim YC
Eur J Med Chem; 2018 May; 151():462-481. PubMed ID: 29649742
[TBL] [Abstract][Full Text] [Related]
16. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
Scarpellino G; Genova T; Munaron L
Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
[TBL] [Abstract][Full Text] [Related]
17. Constructing an atomic-resolution model of human P2X7 receptor followed by pharmacophore modeling to identify potential inhibitors.
Ahmadi M; Nowroozi A; Shahlaei M
J Mol Graph Model; 2015 Sep; 61():243-61. PubMed ID: 26298810
[TBL] [Abstract][Full Text] [Related]
18. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
Giannuzzo A; Pedersen SF; Novak I
Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
[TBL] [Abstract][Full Text] [Related]
19. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.
Jelassi B; Anchelin M; Chamouton J; Cayuela ML; Clarysse L; Li J; Goré J; Jiang LH; Roger S
Carcinogenesis; 2013 Jul; 34(7):1487-96. PubMed ID: 23524196
[TBL] [Abstract][Full Text] [Related]
20. Is pannexin the pore associated with the P2X7 receptor?
Alberto AV; Faria RX; Couto CG; Ferreira LG; Souza CA; Teixeira PC; Fróes MM; Alves LA
Naunyn Schmiedebergs Arch Pharmacol; 2013 Sep; 386(9):775-87. PubMed ID: 23657251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]